Overview
Igor Fijalkowski practices in Gent, Belgium. Mr. Fijalkowski is rated as a Distinguished expert by MediFind in the treatment of SOST-Related Sclerosing Bone Dysplasia. His top areas of expertise are SOST-Related Sclerosing Bone Dysplasia, Adult T-Cell Leukemia, Acromicric Dysplasia, and Syndactyly.
His clinical research consists of co-authoring 24 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of SOST-Related Sclerosing Bone Dysplasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- SOST-Related Sclerosing Bone DysplasiaMr. Fijalkowski isDistinguished. Learn about SOST-Related Sclerosing Bone Dysplasia.
- Advanced
- Adult T-Cell LeukemiaMr. Fijalkowski isAdvanced. Learn about Adult T-Cell Leukemia.
- Experienced
- Acromicric DysplasiaMr. Fijalkowski isExperienced. Learn about Acromicric Dysplasia.
- Acute Lymphoblastic Leukemia (ALL)Mr. Fijalkowski isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- LeukemiaMr. Fijalkowski isExperienced. Learn about Leukemia.
- SyndactylyMr. Fijalkowski isExperienced. Learn about Syndactyly.